Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses
MedicalXpress Breaking News-and-Events | Jul 22, 2022
Vaccine-induced immune response to omicron wanes substantially over time
MedicalXpress Breaking News-and-Events | Jul 22, 2022
Scientists shed new light on how SARS-CoV-2 evades immune response in early infection
MedicalXpress Breaking News-and-Events | Jul 22, 2022
New fast test discriminates between cellular immunity to SARS-CoV-2 after vaccination or infection
MedicalXpress Breaking News-and-Events | Jul 22, 2022
Shorter wait between COVID-19 and elective surgery possible
Newswise | Jul 21, 2022
Influenza surveillance system may have shown early signs of COVID-19 pandemic
MedicalXpress Breaking News-and-Events | Jul 21, 2022
Skin swabs could be how we test for COVID-19 in the future
MedicalXpress Breaking News-and-Events | Jul 21, 2022
COVID-19 patients more likely to develop cardiovascular diseases and diabetes soon after infection
MedicalXpress Breaking News-and-Events | Jul 21, 2022
Pfizer and BioNTech complete submission to European medicines agency for Omicron BA.1 adapted bivalent vaccine candidate
World Pharma News | Jul 21, 2022